Original Report

Pharmaceutical patient assistance programs in the outpatient pharmacy of a large tertiary cancer center


 

References

1. Hede K. Increase in oral cancer drugs raises thorny issues for oncology practices. J Natl Cancer Inst 2009;101:1534–1536.
2. Chisholm MA, DiPiro JT. Pharmaceutical manufacturer assistance programs. Arch Intern Med 2002;162:780–784.
3. Duke KS, Raube K, Lipton HL. Patientassistance programs: assessment of and use by safety-net clinics. Am J Health Syst Pharm 2005;62:726–731.
4. Pisu M, Richman J, Allison JJ, Williams OD, Kiefe CI. Pharmaceuticals companies’ medication assistance programs: potentially useful but too burdensome to use? South Med J 2009;102:139–144.
5. Felder TM, Palmer NR, Lal LS, Mullen PD. What is the evidence for pharmaceutical patient assistance programs? a systematic review. J Health Care Poor Underserved 2011;22:24–49.
6. Meropol NJ, Schrag D, Smith TJ, et al. American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol 2009;27:3868–3874.
7. United States Department of Labor, Bureau of Labor Statistics: Producer Price Index Industry Data—Pharmaceutical Preparation & Manufacturing; 2010 [updated April 26, 2010]. http://www.bls.gov/ppi/data.htm. Accessed June 22, 2011.
8. Hosmer DW, Lemeshow S. Applied Logistic
Logistic
Regression. New York: Wiley; 2000. 9. StataCorp LP. STATA statistical software. 2009; Release 11.
10. Arora S. Use of oral chemotherapeutic medications in non-traditional ambulatory settings; 2009. http://digarchive.library.vcu. edu/dspace/bitstream/10156/2711/1/Thesis_ MPH_sameer.pdf. Accessed June 22, 2011.
11. Cherny NI. The management of cancer pain. CA Cancer J Clin 2000;50:70–116.
12. Williams K. Accessing patient assistance programs to meet clients’ medication needs. J Am Acad Nurse Pract 2000;12:233– 235.
13. National Survey of Households Affected by Cancer: Kaiser Family Foundation; 2006 [updated November 2006]. http://kff.org/kaiserpolls/ upload/7591.pdf. Accessed June 22, 2011.
14. Choudhry NK, Lee JL, Agnew-Blais J, Corcoran C, Shrank WH. Drug company- sponsored patient assistance programs: a viable safety net? Health Aff (Millwood) 2009;28:827–834.
15. Ackerman T. M.D. Anderson submits its records on charitable care: cancer center hopes to quell Iowa senator’s investigation. Houston Chronicle. October 9, 2008. http:// www.chron.com/disp/story.mpl/metropolitan/ 6050254.html. Accessed June 22, 2011.
16. Johnson PE. Patient assistance programs and patient advocacy foundations: alternatives for obtaining prescription medications when insurance fails. Am J Health Syst Pharm 2006;63(21 suppl 7):S13–S17.
17. Weingart SA, Brown E, Bach PB, et al. National Comprehensive Cancer Network task force report: oral chemotherapy. JNCCN 2008;6(suppl 3):S1–S25.

Pages

Recommended Reading

Survey Highlights Survivor Care Issues
MDedge Hematology and Oncology
Survey Highlights Survivor Care Issues
MDedge Hematology and Oncology
Study: Flaxseed Bars Not Effective in Reducing Hot Flashes
MDedge Hematology and Oncology
Screen Breast Cancer Patients for Depression
MDedge Hematology and Oncology
Screen Breast Cancer Patients for Depression
MDedge Hematology and Oncology
New Cancer Patients Struggle to Get Appointments
MDedge Hematology and Oncology
Denosumab Not Cost Effective in Solid Tumor Bone Metastases
MDedge Hematology and Oncology
Novel Anticoagulant Prevents VTEs During Chemotherapy
MDedge Hematology and Oncology
Childhood Cancer Survivors at Higher Risk for Melanoma Risk
MDedge Hematology and Oncology
Video Report: Patient Care Themes and Trends at ASCO 2011
MDedge Hematology and Oncology